highperformr logo

Lupin Pharmaceuticals's Overview

Total employees4736
HeadquartersMumbai
Founded2003

Lupin Limited is an Indian multinational pharmaceutical company and one of the largest generic pharmaceutical companies by revenue globally. Headquartered in Mumbai, India, Lupin is a significant player in the U.S., India, and Japan, along with other regulated and emerging markets. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs across various therapeutic areas including cardiovascular, diabetology, asthma, pediatrics, CNS, GI, anti-infective, and NSAIDs. Lupin is committed to providing affordable healthcare solutions worldwide and is increasingly focusing on complex generics and specialty pharmaceuticals.

Where is Lupin Pharmaceuticals's Headquarters?

HQ Function

Serves as the central hub for global strategic decision-making, corporate governance, R&D oversight, and management of worldwide operations.

Notable Features:

Located in Kalpataru Inspire, a LEED Gold certified building, reflecting a modern and sustainable workspace in a prime business district of Mumbai.

Work Culture:

Lupin fosters a culture centered around its core values of CARE: Customer focus, Achieving excellence, Respect for people, and Ethics & Integrity. It emphasizes innovation, collaboration, and an entrepreneurial spirit among its diverse global workforce.

HQ Significance:

The Mumbai headquarters is pivotal for Lupin's identity as a major Indian multinational, coordinating its extensive R&D, manufacturing, and commercial operations across more than 100 countries.

Values Reflected in HQ: The headquarters' location, design, and operations reflect Lupin's commitment to excellence, sustainability, global connectivity, and ethical business practices.

Location:

Lupin has a robust global presence, with operations in over 100 countries. Key functions supported globally include research and development, state-of-the-art manufacturing of APIs and formulations, quality control, regulatory affairs, and extensive marketing and distribution networks. The company has a significant footprint in markets like India, the United States, Japan, Europe, Latin America, Australia, and South Africa, with multiple manufacturing plants and R&D centers strategically located worldwide.

Street Address:

Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East)

City:

Mumbai

State/Province:

Maharashtra

Country:

India

Lupin Pharmaceuticals's Global Presence

Baltimore, Maryland, USA

Address: Harborplace Tower, 111 S. Calvert Street, Suite 1550, Baltimore, MD 21202, USA

Manages and supports Lupin's significant presence in the United States, which is one of its largest markets for generic and specialty pharmaceuticals.

Somerset, New Jersey, USA

Address: Various facilities including 400 Campus Drive, Somerset, NJ 08873, USA

Drives pharmaceutical innovation, product development, and manufacturing to supply the U.S. market and support Lupin's global product pipeline.

Zug, Switzerland

Address: Dammstrasse 19, 6300 Zug, Switzerland

Facilitates market access, commercial operations, and business development within the European Union and other European markets.

Buying Intent Signals for Lupin Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Lupin Pharmaceuticals

As of April 2025, Lupin Pharmaceuticals' leadership includes:

Vinita Gupta - Chief Executive Officer
Nilesh Gupta - Managing Director
Christoph Funke - Chief Financial Officer
Dr. Ranjana Pathak - Chief Quality & Compliance Officer
Dr. Fabrice Egros - President - Corporate Development and Growth Markets
Spiro Gavaris - President - U.S. Generics
Naresh Gupta - President - API & Global Novel Molecules
Yashwant Mahadik - President - Global Human Resources
Diana V. Desai - President - Legal and Company Secretary

Investors of Lupin Pharmaceuticals

Lupin Pharmaceuticals has been backed by several prominent investors over the years, including:

Promoter Group (Gupta Family & Associates)
Life Insurance Corporation of India (LIC)
SBI Funds Management Ltd
Various Foreign Portfolio Investors (FPIs) and Domestic Institutional Investors (DIIs)

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits1

Lupin Pharmaceuticals has experienced significant leadership updates in the past year, most notably the appointment of a new Chief Financial Officer, Christoph Funke, who succeeded Ramesh Swaminathan. The company also strengthened its API business leadership with the appointment of Dr. Shahin Fesharaki.

Departures

Ramesh Swaminathan, Ramesh Swaminathan stepped down from his role as Global CFO, effective December 31, 2023.

New Appointments:

Christoph Funke, Christoph Funke appointed as new Chief Financial Officer.
Dr. Shahin Fesharaki, Dr. Shahin Fesharaki appointed to lead the Global API Business.

Technology (Tech Stack) used by Lupin Pharmaceuticals

Discover the tools Lupin Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Lupin Pharmaceuticals Email Formats and Examples

Lupin Pharmaceuticals primarily uses the [first][last]@lupin.com email format. Other variations might exist but this is reported as the most common.

[first][last]@lupin.com

Format

janedoe@lupin.com

Example

75%

Success rate

News and media

Lupin Official Website / BSE IndiaMay 8, 2024

Lupin Pharmaceuticals Announces Audited Financial Results for Q4 and FY2024

Lupin Limited announced its audited financial results for the fourth quarter and full financial year ending March 31, 2024, highlighting key performance indicators, revenue growth, and profitability metrics....more

Lupin Official Website / FDA NewsMay 2, 2024

Lupin Pharmaceuticals Receives U.S. FDA Approval for Bromfenac Ophthalmic Solution, 0.07%

Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Bromfenac Ophthalmic Solution, 0.07%, a generic equivalent of BromSite® Ophthalmic Solution, 0.075%, of Sun Pharmaceutical Industries Limited....more

Lupin Official Website / FDA NewsApril 22, 2024

Lupin Pharmaceuticals Receives U.S. FDA Approval for Mirabegron Extended-Release Tablets, USP

Lupin received approval from the U.S. FDA for its ANDA for Mirabegron Extended-Release Tablets, USP, 25 mg and 50 mg, a generic equivalent of Myrbetriq® Extended-Release Tablets of Astellas Pharma Global Development, Inc. This product will be manufactured at Lupin’s Pithampur facility in India....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Lupin Pharmaceuticals, are just a search away.